CoChat

Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae

Becker, Argentina, Kannan, T. R., Taylor, Alexander B., Pakhomova, Olga N., Zhang, Yanfeng, Somarajan, Sudha R., Galaleldeen, Ahmad, Holloway, Stephen P., Baseman, Joel B., Hart, P. John · 2015 · Proceedings of the National Academy of Sciences
Cited by 84

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Significance: The airway pathogen Mycoplasma pneumoniae ( Mp ) produces a virulence factor with ADP-ribosyltransferase and vacuolating activities known as Community-Acquired Respiratory Distress Syndrome Toxin (CARDS TX). Mammalian cells exposed to recombinant CARDS TX exhibit distinct patterns of ADP-ribosylated proteins and unusual vacuolation phenotypes with disruption of monolayer integrity, leading to cell death. Recombinant CARDS TX administered to naive mice induces an allergic-type inflammatory response and airway hyperreactivity, suggesting that an analogous response in humans may play a causal role in Mp -associated asthma. Here we present the structure of CARDS TX, the newest member of the well-recognized group of ADP-ribosylating toxins. The structure enhances understanding of Mp pathogenicity and provides a platform for the development of therapies to treat Mp -associated acute and chronic airway diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1420308112

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Mycoplasma pneumoniae and Its Role as a Human Pathogen

    Waites, K. B., & Talkington, D. F. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.697-728.2004 · Cited by 1,339 · cited 3×

    “The bacterium is best known as a cause of atypical, or “walking,” pneumonia (2, 3) and is increasingly appreciated for its role in the etiology of reactive airway diseases, such as asthma and adult respiratory distress syndrome (ARDS) (4, 5).”
    Background

Show all 1 references

Research works printed but not linked: 47

  1. JB Baseman, JG Tully, Mycoplasmas: Sophisticated, reemerging, and burdened by their notoriety. Emerg Infect Dis 3, 21–32 (1997). · DOI · Paper page
  2. N Nisar, R Guleria, S Kumar, T Chand Chawla, N Ranjan Biswas, Mycoplasma pneumoniae and its role in asthma. Postgrad Med J 83, 100–104 (2007). · DOI
  3. J Peters, , Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma. Chest 140, 401–407 (2011). · DOI
  4. JB Baseman, SP Reddy, SF Dallo, Interplay between mycoplasma surface proteins, airway cells, and the protean manifestations of mycoplasma-mediated human infections. Am J Respir Crit Care Med 154, S137–S144 (1996). · DOI
  5. CP Berg, , Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis. Liver Int 29, 797–809 (2009). · DOI · Paper page
  6. DF Talkington, KB Waites, SB Schwartz, RE Besser Emerging From Obscurity: Understanding Pulmonary and Extrapulmonary Syndromes, Pathogenesis, and Epidemiology of Human Mycoplasma pneumoniae Infections (American Society for Microbiology, Washington, DC, 2001).
  7. PC Hu, AM Collier, JB Baseman, Interaction of virulent Mycoplasma pneumoniae with hamster tracheal organ cultures. Infect Immun 14, 217–224 (1976). · doi:10.1128/iai.14.1.217-224.1976
  8. MD Eaton, G Meiklejohn, W van Herick, M Corey, Studies on the etiology of primary atypical pneumonia, I: Properties of the virus isolated and propagated in chick embryos. J Exp Med 82, 317–328 (1945). · doi:10.1084/jem.82.5.317
  9. MA Meseguer, , Mycoplasma pneumoniae: A reduced-genome intracellular bacterial pathogen. Infect Genet Evol 3, 47–55 (2003). · DOI · Paper page
  10. TR Kannan, JB Baseman, ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc Natl Acad Sci USA 103, 6724–6729 (2006). · DOI · Paper page
  11. TR Kannan, D Provenzano, JR Wright, JB Baseman, Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae. Infect Immun 73, 2828–2834 (2005). · doi:10.1128/iai.73.5.2828-2834.2005
  12. JR Wright, Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 5, 58–68 (2005). · DOI · Paper page
  13. TR Kannan, , Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin expression reveals growth phase- and infection-dependent regulation. Mol Microbiol 76, 1127–1141 (2010). · DOI · Paper page
  14. RD Hardy, , Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin. PLoS ONE 4, e7562 (2009). · DOI
  15. JL Medina, , Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation. Am J Respir Cell Mol Biol 46, 815–822 (2012). · DOI
  16. C Johnson, TR Kannan, JB Baseman, Cellular vacuoles induced by Mycoplasma pneumoniae CARDS toxin originate from Rab9-associated compartments. PLoS ONE 6, e22877 (2011). · DOI · Paper page
  17. SR Somarajan, , Annexin A2 mediates Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin binding to eukaryotic cells. MBio 5 (2014). · DOI
  18. S Bose, , ADP-ribosylation of NLRP3 by Mycoplasma pneumoniae CARDS toxin regulates inflammasome activity. MBio 5, e02186–14 (2014). · DOI
  19. G dos Santos, MA Kutuzov, KM Ridge, The inflammasome in lung diseases. Am J Physiol Lung Cell Mol Physiol 303, L627–L633 (2012). · DOI · Paper page
  20. ON Pakhomova, , Crystallization of community-acquired respiratory distress syndrome toxin from Mycoplasma pneumoniae. Acta Crystallogr Sect F Struct Biol Cryst Commun 66, 294–296 (2010). · DOI
  21. L Holm, C Sander, Dali: A network tool for protein structure comparison. Trends Biochem Sci 20, 478–480 (1995). · DOI · Paper page
  22. PE Stein, , The crystal structure of pertussis toxin. Structure 2, 45–57 (1994). · DOI · Paper page
  23. CJ O’Neal, MG Jobling, RK Holmes, WG Hol, Structural basis for the activation of cholera toxin by human ARF6-GTP. Science 309, 1093–1096 (2005). · DOI
  24. M Domenighini, R Rappuoli, Three conserved consensus sequences identify the NAD-binding site of ADP-ribosylating enzymes, expressed by eukaryotes, bacteria and T-even bacteriophages. Mol Microbiol 21, 667–674 (1996). · DOI
  25. TR Kannan, , Functional mapping of community-acquired respiratory distress syndrome (CARDS) toxin of Mycoplasma pneumoniae defines regions with ADP-ribosyltransferase, vacuolating and receptor-binding activities. Mol Microbiol 93, 568–581 (2014). · DOI · Paper page
  26. S Han, JA Tainer, The ARTT motif and a unified structural understanding of substrate recognition in ADP-ribosylating bacterial toxins and eukaryotic ADP-ribosyltransferases. Int J Med Microbiol 291, 523–529 (2002). · doi:10.1078/1438-4221-00162
  27. E Rutenber, JD Robertus, Structure of ricin B-chain at 2.5-A resolution. Proteins 10, 260–269 (1991). · DOI · Paper page
  28. D Nesić, Y Hsu, CE Stebbins, Assembly and function of a bacterial genotoxin. Nature 429, 429–433 (2004). · DOI · Paper page
  29. D Nesic, CE Stebbins, Mechanisms of assembly and cellular interactions for the bacterial genotoxin CDT. PLoS Pathog 1, e28 (2005). · DOI
  30. G van Meer, DR Voelker, GW Feigenson, Membrane lipids: Where they are and how they behave. Nat Rev Mol Cell Biol 9, 112–124 (2008). · DOI · Paper page
  31. R Veldhuizen, K Nag, S Orgeig, F Possmayer, The role of lipids in pulmonary surfactant. Biochim Biophys Acta 1408, 90–108 (1998). · DOI · Paper page
  32. S Schurch, H Bachofenb, F Possmayer, Pulmonary surfactant: Surface properties and function of alveolar and airway surfactant. Pure Appl Chem 64, 1745–1750 (1992). · doi:10.1351/pac199264111745
  33. F Shang, , Crystallographic complexes of surfactant protein A and carbohydrates reveal ligand-induced conformational change. J Biol Chem 286, 757–765 (2011). · DOI
  34. P Stenmark, J Dupuy, A Imamura, M Kiso, RC Stevens, Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin–neuron interaction. PLoS Pathog 4, e1000129 (2008). · DOI · Paper page
  35. RJ Fieldhouse, AR Merrill, Needle in the haystack: Structure-based toxin discovery. Trends Biochem Sci 33, 546–556 (2008). · DOI
  36. RG Zhang, , The three-dimensional crystal structure of cholera toxin. J Mol Biol 251, 563–573 (1995). · DOI · Paper page
  37. EA Merritt, TK Sixma, KH Kalk, BA van Zanten, WG Hol, Galactose-binding site in Escherichia coli heat-labile enterotoxin (LT) and cholera toxin (CT). Mol Microbiol 13, 745–753 (1994). · DOI · Paper page
  38. N Treiber, DJ Reinert, I Carpusca, K Aktories, GE Schulz, Structure and mode of action of a mosquitocidal holotoxin. J Mol Biol 381, 150–159 (2008). · doi:10.1016/j.jmb.2008.05.067
  39. S Olsnes, A Pihl, Different biological properties of the two constituent peptide chains of ricin, a toxic protein inhibiting protein synthesis. Biochemistry 12, 3121–3126 (1973). · DOI · Paper page
  40. Z Otwinowski, W Minor, Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276, 307–326 (1997). · DOI · Paper page
  41. GM Sheldrick, A short history of SHELX. Acta Crystallogr A 64, 112–122 (2008). · DOI · Paper page
  42. G Bricogne, C Vonrhein, C Flensburg, M Schiltz, W Paciorek, Generation, representation and flow of phase information in structure determination: Recent developments in and around SHARP 2.0. Acta Crystallogr D Biol Crystallogr 59, 2023–2030 (2003). · DOI · Paper page
  43. TC Terwilliger, Maximum-likelihood density modification. Acta Crystallogr D Biol Crystallogr 56, 965–972 (2000). · DOI · Paper page
  44. PD Adams, , PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66, 213–221 (2010). · DOI · Paper page
  45. P Emsley, K Cowtan, Coot: Model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126–2132 (2004). · DOI · Paper page
  46. ; Collaborative Computational Project, Number 4, The CCP4 suite: Programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50, 760–763 (1994). · DOI · Paper page
  47. M Krishnan, TR Kannan, JB Baseman, Mycoplasma pneumoniae CARDS toxin is internalized via clathrin-mediated endocytosis. PLoS ONE 8, e62706 (2013). · DOI · Paper page

Cited by

See all 84

Metadata

Authors
Becker, A., Kannan, T. R., Taylor, A. B., Pakhomova, O. N., Zhang, Y., Somarajan, S. R., Galaleldeen, A., Holloway, S. P., Baseman, J. B., & Hart, P. J.
Affiliations
  • Department of Biochemistry,
  • Department of Microbiology and Immunology/Center for Airway Inflammation Research, and
Venue
Proceedings of the National Academy of Sciences
Published
2015-04-06
Volume
112
Issue
16
Pages
5165-5170
ISSN
  • 0027-8424
  • 1091-6490
Cited by
84
References
1
Language
en
Funders
  • Office of Extramural Research, National Institutes of Health (U19 AI070412)
  • Welch Foundation (AQ-1399)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae. https://app.cochat.ai/papers/10.1073/pnas.1420308112
The paper
Becker, A., Kannan, T. R., Taylor, A. B., Pakhomova, O. N., Zhang, Y., Somarajan, S. R., Galaleldeen, A., Holloway, S. P., Baseman, J. B., & Hart, P. J. (2015). Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1420308112

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.